z-logo
Premium
Pituitary apoplexy during treatment with dabigatran
Author(s) -
Uemura Masahiro,
Miyashita Fumio,
Shimomura Ryo,
Fujinami Jun,
Toyoda Kazunori
Publication year - 2013
Publication title -
neurology and clinical neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
0
ISSN - 2049-4173
DOI - 10.1002/ncn3.18
Subject(s) - medicine , dabigatran , pituitary apoplexy , anesthesia , atrial fibrillation , pituitary adenoma , warfarin , adenoma
Pituitary apoplexy is known as an uncommon complication of pituitary adenoma, and anticoagulant therapy has been reported as one of the precipitating factors. We report an 85‐year‐old man who developed pituitary apoplexy during treatment with dabigatran. His medical history included a non‐functioning pituitary adenoma and non‐valvular atrial fibrillation. Headache occurred 4 days after changing the anticoagulant from warfarin to dabigatran; and other neurological symptoms, such as ptosis and ophthalmoplegia, subsequently developed. On admission, laboratory examination showed a prolonged activated partial thromboplastin time and moderately decreased kidney dysfunction. Emergency magnetic resonance imaging ( MRI) showed pituitary hemorrhage in the tumor. Although dabigatran was reported to cause intracranial hemorrhage less commonly than warfarin, it could cause uncommon bleeding like in the present case.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom